Literature DB >> 15662973

Hyperthermia induces translocation of apoptosis-inducing factor (AIF) and apoptosis in human glioma cell lines.

Tadateru Fukami1, Satoshi Nakasu, Kazumi Baba, Masayuki Nakajima, Masayuki Matsuda.   

Abstract

In the hyperthermal treatment, the wild type (wt) p53 plays an important role in apoptosis induction in the tumor cells. In human gliomas, p53 frequently has some form of mutation. The mutant type (mt) p53 does not work properly as a tumor suppressor and this may result in poor responses during treatment. We investigated the relationship between apoptosis-inducing factor (AIF) and apoptosis under various thermal conditions (43, 45, and 47 degrees C for 1 h) using four p53-wild or -mutant human glioma cell lines (A172, T98G, U251MG, and YKG-1). AIF translocation from the mitochondria to the nucleus under hyperthermal conditions was demonstrated by confocal laser microscopy. The percentage of AIF-positive nuclei increased significantly in comparison with the control in all cell lines and in all temperature groups except for YKG-1 at 47 degrees C. Immunoblot analyses of the nuclear fraction of each cell line revealed temperature-dependent increases in AIF. A simultaneous release of cytochrome c from the mitochondria to the cytosol was noted. A flow cytometric analysis showed that apoptosis induction occurred more often in a temperature-dependent manner in the 45 and 47 degrees C groups than in the control group. These findings indicate that the hyperthermal conditions can lead to AIF translocation and apoptotic cell death in the p53-mutant human glioma cells. The present report is the first description of AIF-induced apoptosis in hyperthermia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15662973     DOI: 10.1007/s11060-004-9168-0

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  57 in total

1.  Bid acts on the permeability transition pore complex to induce apoptosis.

Authors:  N Zamzami; C El Hamel; C Maisse; C Brenner; C Muñoz-Pinedo; A S Belzacq; P Costantini; H Vieira; M Loeffler; G Molle; G Kroemer
Journal:  Oncogene       Date:  2000-12-14       Impact factor: 9.867

2.  Concomitant p53 gene mutation and increased radiosensitivity in rat lung embryo epithelial cells during neoplastic development.

Authors:  D S Biard; M Martin; Y L Rhun; A Duthu; J L Lefaix; E May; P May
Journal:  Cancer Res       Date:  1994-07-01       Impact factor: 12.701

3.  Molecular mechanisms of sulfasalazine-induced T-cell apoptosis.

Authors:  Susanne Liptay; Simone Fulda; Marta Schanbacher; Soizic Bourteele; Karine F Ferri; Guido Kroemer; Guido Adler; Klaus M Debatin; Roland M Schmid
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

4.  Predicting chemoresistance in human malignant glioma cells: the role of molecular genetic analyses.

Authors:  M Weller; J Rieger; C Grimmel; E G Van Meir; N De Tribolet; S Krajewski; J C Reed; A von Deimling; J Dichgans
Journal:  Int J Cancer       Date:  1998-12-18       Impact factor: 7.396

Review 5.  Apoptosis. Its significance in cancer and cancer therapy.

Authors:  J F Kerr; C M Winterford; B V Harmon
Journal:  Cancer       Date:  1994-04-15       Impact factor: 6.860

6.  p53 mutations increase resistance to ionizing radiation.

Authors:  J M Lee; A Bernstein
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

7.  DNA binding is required for the apoptogenic action of apoptosis inducing factor.

Authors:  Hong Ye; Celine Cande; Nicolas C Stephanou; Sulin Jiang; Sundeep Gurbuxani; Nathanael Larochette; Eric Daugas; Carmen Garrido; Guido Kroemer; Hao Wu
Journal:  Nat Struct Biol       Date:  2002-09

8.  Bcl-2 inhibits the mitochondrial release of an apoptogenic protease.

Authors:  S A Susin; N Zamzami; M Castedo; T Hirsch; P Marchetti; A Macho; E Daugas; M Geuskens; G Kroemer
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

9.  Mitochondrial control of nuclear apoptosis.

Authors:  N Zamzami; S A Susin; P Marchetti; T Hirsch; I Gómez-Monterrey; M Castedo; G Kroemer
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

Review 10.  The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis.

Authors:  A J Levine; M E Perry; A Chang; A Silver; D Dittmer; M Wu; D Welsh
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

View more
  13 in total

1.  Functionalized nano-graphene oxide particles for targeted fluorescence imaging and photothermy of glioma U251 cells.

Authors:  Zhong-Jun Li; Chao Li; Mei-Guang Zheng; Jia-Dong Pan; Li-Ming Zhang; Yue-Fei Deng
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 2.  [Treatment of brain tumor patients: hyperthermia, hyperbaric oxygenation, electric fields or nanoparticles].

Authors:  M Platten; W Wick
Journal:  Nervenarzt       Date:  2012-08       Impact factor: 1.214

Review 3.  Magnetic hyperthermia therapy for the treatment of glioblastoma: a review of the therapy's history, efficacy and application in humans.

Authors:  Keon Mahmoudi; Alexandros Bouras; Dominique Bozec; Robert Ivkov; Constantinos Hadjipanayis
Journal:  Int J Hyperthermia       Date:  2018-02-06       Impact factor: 3.914

4.  Design of "smart" probes for optical imaging of apoptosis.

Authors:  Xinglu Huang; Seulki Lee; Xiaoyuan Chen
Journal:  Am J Nucl Med Mol Imaging       Date:  2011-06-22

5.  Simultaneous delivery of chemotherapeutic and thermal-optical agents to cancer cells by a polymeric (PLGA) nanocarrier: an in vitro study.

Authors:  Yuan Tang; Tingjun Lei; Romila Manchanda; Abhignyan Nagesetti; Alicia Fernandez-Fernandez; Supriya Srinivasan; Anthony J McGoron
Journal:  Pharm Res       Date:  2010-08-06       Impact factor: 4.200

6.  Multifunctional organically modified silica nanoparticles for chemotherapy, adjuvant hyperthermia and near infrared imaging.

Authors:  Abhignyan Nagesetti; Anthony J McGoron
Journal:  Colloids Surf B Biointerfaces       Date:  2016-08-18       Impact factor: 5.268

7.  Hyperthermia sensitizes Rhizopus oryzae to posaconazole and itraconazole action through apoptosis.

Authors:  Fazal Shirazi; Michael A Pontikos; Thomas J Walsh; Nathaniel Albert; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2013-07-01       Impact factor: 5.191

8.  Long-term infection and shedding of human cytomegalovirus in T98G glioblastoma cells.

Authors:  Min Hua Luo; Elizabeth A Fortunato
Journal:  J Virol       Date:  2007-07-25       Impact factor: 5.103

9.  Covalent IR820-PEG-diamine nanoconjugates for theranostic applications in cancer.

Authors:  Alicia Fernandez-Fernandez; Romila Manchanda; Denny A Carvajal; Tingjun Lei; Supriya Srinivasan; Anthony J McGoron
Journal:  Int J Nanomedicine       Date:  2014-10-06

10.  Hyperthermia and chemotherapy using Fe(Salen) nanoparticles might impact glioblastoma treatment.

Authors:  Makoto Ohtake; Masanari Umemura; Itaru Sato; Taisuke Akimoto; Kayoko Oda; Akane Nagasako; Jeong-Hwan Kim; Takayuki Fujita; Utako Yokoyama; Tomohiro Nakayama; Yujiro Hoshino; Mai Ishiba; Susumu Tokura; Masakazu Hara; Tomoya Muramoto; Sotoshi Yamada; Takatsugu Masuda; Ichio Aoki; Yasushi Takemura; Hidetoshi Murata; Haruki Eguchi; Nobutaka Kawahara; Yoshihiro Ishikawa
Journal:  Sci Rep       Date:  2017-02-20       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.